Skip to main content
VaccineWatch
VaccinesSymptomsStatesAnalysisToolsDashboardCompare

VaccineWatch

Transparent access to VAERS data for informed decision-making. We present the data as-is, with appropriate context and disclaimers.

Explore Data

  • Vaccines
  • Symptoms
  • Manufacturers
  • States
  • Dashboard
  • Compare Tool
  • Search

Deep Dives

  • The Denominator Problem
  • Onset Timing
  • Lot Number Analysis
  • COVID Impact
  • Myocarditis
  • Death Reports
  • Interactive Tools
  • All 23 Articles →

Resources

  • About
  • Methodology
  • FAQ
  • Glossary
  • Side Effects Guide
  • Vaccine Schedule
  • Vaccine Safety
  • Safety Timeline
  • Adverse Events
  • Is VAERS Reliable?
  • Report an Event
  • Disclaimer
  • VAERS Official Site ↗

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending
  • OpenMedicare
  • OpenLobby
  • TheDataProject.ai

Data source: VAERS (Vaccine Adverse Event Reporting System)

Data through 2026 · Updated quarterly

Built by TheDataProject.ai · © 2026 VaccineWatch

Important: VAERS accepts reports of adverse events following vaccination. For any given report, there is no certainty that the reported event was caused by the vaccine. Reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. Most reports to VAERS are voluntary, which means they are subject to biases. This data cannot be used to determine if vaccines cause or contribute to adverse events.

⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

  1. Home
  2. Vaccines
  3. DTaP
  4. Upper respiratory tract infection
DTaP×Upper respiratory tract infection

Upper respiratory tract infection Reports for DTaP

#163 most reported symptom for this vaccine

183
Reports
13
Deaths
51
Hospitalizations
7.1
Mortality Rate
%
27.9
Hosp. Rate
%

Upper respiratory tract infection and DTaP

Upper respiratory tract infection has been reported 183 times in association with DTaP vaccination in VAERS. This represents 0.3% of all 66,714 reports for this vaccine.

Among these reports, 13 mentioned death (7.10%) and 51 involved hospitalization (27.9%).

Upper respiratory tract infection is the #163 most frequently reported symptom for DTaP out of 1943 total symptoms.

Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.

What This Means

Seeing 183 reports of Upper respiratory tract infection after DTaP vaccination may seem alarming, but context is critical.

The 7.10% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.

Important Context

•Association, not causation: These reports show Upper respiratory tract infection occurred after vaccination, not that the vaccine caused it.
•Background rates: Upper respiratory tract infection may occur naturally at baseline rates in the population, unrelated to vaccination.
•Anyone can report: VAERS accepts reports from anyone — patients, parents, healthcare providers — without requiring medical verification.
•Denominator missing: VAERS counts reports, not rates per dose. Without knowing how many doses were given, raw counts can be misleading. Learn more →

Similarly Ranked Symptoms

Injection site discolouration185 reportsAphasia184 reportsPertussis182 reportsInappropriate schedule of product administration180 reports

Quick Facts

Reports:183
Deaths:13
Hospitalizations:51
% of Vaccine:0.3%
Rank:#163 of 1943

Related Pages

DTaP OverviewUpper respiratory tract infection (All Vaccines)Why Raw Numbers MisleadTop Symptoms Analysis

Data Source

This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.